US Stocks
/
Cardiol Therapeutics Inc. Class A Share Price

Cardiol Therapeutics Inc. Class A Share Price

NASDAQ: CRDL
$1.31
+$0.02 (1.16%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cardiol Therapeutics Inc. Class A Stock Performance

Open
$1.29
Prev. Close
$1.29
Circuit Range
N/A
Day Range
$1.29 - $1.34
Year Range
$0.88 - $2.34
Volume
54,214
Average Traded
$1.31

Cardiol Therapeutics Inc. Class A Share Price Today

As of 9 October 2026, Cardiol Therapeutics Inc. Class A's share price is $1.31. The stock opened at $1.29, compared to its previous close of $1.29. During today's trading session, Cardiol Therapeutics Inc. Class A's share price traded between $1.29 and $1.34, with an average price of $1.31. Over the past 52 weeks, the stock has recorded a high of $2.34 and a low of $0.88. In terms of performance, Cardiol Therapeutics Inc. Class A's share price has declined by 5.07% over the last six months and is up 15.93% on a year-on-year basis.

Cardiol Therapeutics Inc. Class A Share Price Chart

$1.29$1.34
L
Show Current Price
H

Cardiol Therapeutics Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Cardiol Therapeutics Inc. Class A

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Cardiol Therapeutics Inc. Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.64
$1.31
-21.32%
Sep 2026
$1.95
$1.67
-19.17%
Aug 2026
$1.23
$2.06
+63.49%
Jul 2026
$1.06
$1.26
+20.00%
Jun 2026
$1.24
$1.05
-13.93%
May 2026
$1.36
$1.22
-11.59%
Apr 2026
$1.39
$1.38
+1.85%
Mar 2026
$1.01
$1.35
+32.84%
Feb 2026
$0.94
$1.02
+7.37%
Jan 2026
$0.98
$0.95
-0.73%
Dec 2025
$1.10
$0.96
-8.42%
Nov 2025
$1.14
$1.04
-7.52%

CRDL Share Price FAQs

What is Cardiol Therapeutics Inc. Class A share price today?

chevron-up
Cardiol Therapeutics Inc. Class A share price today is $1.31 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cardiol Therapeutics Inc. Class A stock?

chevron-up
The 52 week high of Cardiol Therapeutics Inc. Class A stock is $2.34, while the 52 week low is $0.88 as of 9 Oct '26.

What is the 5 year returns of CRDL?

chevron-up
The 5 year returns of CRDL is -63.91% as on 9 Oct '26.

What is the high & low stock price of CRDL today?

chevron-up
CRDL stock price hit a high of $1.34 and low of $1.29 as of 9 Oct '26.

Can I buy CRDL shares in India?

chevron-up
Yes. You can buy CRDL in India by opening an international trading account.